Identifying Opportunities to Improve Aspirin Utilization for the Primary Prevention of Cardiovascular Disease in A Regional Health care System

Wisconsin Medical Journal

Volumn 113, Issue 5, 2014, Pages 190-195

  Vanwormer, Jeffrey J ^a   Miller, Aaron W ^a   Rezkalla, Shereif H ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DRUG EXPOSURE; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; FEMALE; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; MALE; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SMOKING; CARDIOVASCULAR DISEASES; ELECTRONIC MEDICAL RECORD; HEALTH CARE PLANNING; PRIMARY PREVENTION; UNITED STATES;

ANTICOAGULANTS; ASPIRIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIMARY PREVENTION; REGIONAL HEALTH PLANNING; WISCONSIN;

EID: 84914162009     PISSN: 10981861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2013 update: A report from the American Heart Association. Circulation. 2013;127:e6-e245.
2. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in US deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356:2388-2398.
3. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association. Circulation. 2011;123:933-944.
4. Hsu S, Ton VK, Dominique Ashen M, et al. A clinician’s guide to the ABCs of cardiovascular disease prevention: The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease and American College of Cardiology Cardiosource approach to the Million Hearts Initiative. Clin Cardiol. 2013;36:383-393.
5. Hennekens CH, Schneider WR. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease. Expert Rev Cardiovasc Ther. 2008;6:95-107.
6. US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: US preventive services task force recommendation statement. Ann Intern Med. 2009;150:396-404.
7. Barnett H, Burrill P, Iheanacho I. Don’t use aspirin for primary prevention of cardiovascular disease. BMJ. 2010;340:c1805.
8. US Food and Drug Administration. Use of Aspirin for Primary Prevention of Heart Attack and Stroke. www.fda.gov/drugs/resourcesforyou/consumers/ucm390574.htm. Accessed August 25, 2014.
9. Bartolucci AA, Tendera M, Howard G. Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin. Am J Cardiol. 2011;107:1796-1801.
10. Ajani UA, Ford ES, Greenland KJ, Giles WH, Mokdad AH. Aspirin use among US adults: Behavioral Risk Factor Surveillance System. Am J Prev Med. 2006;30:74-77.
11. Sanchez DR, Diez Roux AV, Michos ED, et al. Comparison of the racial/ethnic prevalence of regular aspirin use for the primary prevention of coronary heart disease from the multi-ethnic study of atherosclerosis. Am J Cardiol. 2011;107:41-46.
12. Pignone M, Anderson GK, Binns K, Tilson HH, Weisman SM. Aspirin use among adults aged 40 and older in the United States: Results of a national survey. Am J Prev Med. 2007;32:403-407.
13. Wisconsin Collaborative for Healthcare Quality. Ischemic Vascular Disease: Daily Aspirin or Other Antiplatelet Therapy. www.wchq.org/reporting/results.php?category_id=0&topic_id=27&source:id=0&providerType=0®ion=0&measure_id=156. Accessed August 25, 2014.
14. VanWormer JJ, Greenlee RT, McBride PE, et al. Aspirin for primary prevention of CVD: Are the right people using it? J Fam Pract. 2012;61:525-532.
15. VanWormer JJ. Methods of using the electronic health record for population level surveillance of coronary heart disease risk in the Heart of New Ulm project. Diabetes Spectrum. 2010;23:161-165.
16. Pakhomov SV, Shah ND, Hanson P, Balasubramaniam SC, Smith SA. Automated processing of electronic medical records is a reliable method of determining aspirin use in populations at risk for cardiovascular events. Inform Prim Care. 2010;18:125-133.
17. Persell SD, Dunne AP, Lloyd-Jones DM, Baker DW. Electronic health record-based cardiac risk assessment and identification of unmet preventive needs. Med Care. 2009;47:418-424.
18. DeStefano F, Eaker ED, Broste SK, et al. Epidemiologic research in an integrated regional medical care system: The Marshfield Epidemiologic Study Area. J Clin Epidemiol. 1996;4:643-652.
19. Greenlee RT. Measuring disease frequency in the Marshfield Epidemiologic Study Area (MESA). Clin Med Res. 2003;1:273-280.
20. Pignone M, Alberts MJ, Colwell JA, et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: A position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Diabetes Care. 2010;33:1395-1402.
21. D’Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743-753.
22. Minnesota Community Measurement. Optimal Vascular Care 2013 Data Collection Guide. http://mncm.org/wp-content/uploads/2013/04/Optimal_Vascular_Care_DDS_2013_FINAL_11_27_2012.pdf. Accessed August 25, 2014.
23. Miser WF. Appropriate aspirin use for primary prevention of cardiovascular disease. Am Fam Physician. 2011;83:1380-1386.
24. Zantek ND, Luepker RV, Duval S, et al. Confirmation of reported aspirin use in community studies: Utility of serum thromboxane B2 measurement. Clin Appl Thromb Hemost. 2014; 20: 385-392.
25. American Society of Health-System Pharmacists. AHFS Drug Information 2013. Bethesda, MD: American Society of Health-System Pharmacists; 2013.
26. Onitilo AA, Miskowiak D, Broton M, et al. Geographical access to mammography services and stage of breast cancer at initial diagnosis in Wisconsin. Poster session presented at: Annual HMO Research Network Conference; 2013 Apr 16; San Francisco, CA.
27. Gabbert JP, Trine RM, Bintz M. Improving a regional outreach program in a large health system using geographic information systems. WMJ. 2012;111(3):134-137.